See also this year's filing and all EDGAR filings for this company.
PDF Report 0001438533_2023_Travere_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001438533, Travere Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 486,437,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 145,038,000 |
| 2 | PropertyPlantAndEquipmentNet | 9,049,000 |
| 3 | remainder_Assets | 32,061,000 |
| 4 | LiabilitiesCurrent | 142,163,000 |
| 5 | LiabilitiesNoncurrent | 47,826,000 |
| 6 | remainder_Liabilities | 439,745,000 |
| 7 | CostOfGoodsAndServicesSold | 7,592,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 220,206,000 |
| 9 | ResearchAndDevelopmentExpense | 235,780,000 |
| 10 | remainder_Expenses | 15,319,000 |
| 11 | remainder_Revenues | 212,018,000 |
| 12 | remainder_NetIncome | -11,603,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,345,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 672,585,000 |
| 1 | Liabilities | 629,734,000 |
| 2 | Expenses | 478,897,000 |
| 3 | Revenues | 212,018,000 |
| 4 | StockholdersEquity | 42,851,000 |
| 5 | NetIncome | -278,482,000 |
| 6 | ComprehensiveNetIncome | -279,654,500 |
| 7 | BaseVar | 1,003,591,000 |
| 8 | EconomicCapitalRatio | -0.316 |
Edgar->Model Mapping
Feature Distribution
Change over Time
